Premium
Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant
Author(s) -
Daniel A.,
d' Emden M.,
Duncan E.
Publication year - 2013
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12077
Subject(s) - medicine , pegvisomant , gigantism , growth hormone , acromegaly , hormone
A Caucasian male aged 15 years presented with 2 years\udaccelerated linear growth. He was 202 cm tall at\udpresentation, with calculated mid-parental height of\ud173 cm. There were no features of hypopituitarism or\udacral growth. His visual fields and optic discs were\udnormal..